CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 69 filers reported holding CIDARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,857 | -79.0% | 56,100 | -74.9% | 0.00% | -100.0% |
Q2 2023 | $252,231 | +48.8% | 223,213 | +67.2% | 0.00% | – |
Q1 2023 | $169,545 | +897.3% | 133,500 | +550.2% | 0.00% | – |
Q1 2022 | $17,000 | -94.8% | 20,532 | -92.0% | 0.00% | -100.0% |
Q4 2021 | $326,000 | -61.0% | 256,332 | -31.3% | 0.00% | -50.0% |
Q3 2021 | $836,000 | +646.4% | 373,338 | +571.5% | 0.00% | – |
Q2 2021 | $112,000 | -78.5% | 55,599 | -71.7% | 0.00% | -100.0% |
Q1 2021 | $522,000 | +275.5% | 196,157 | +181.3% | 0.00% | – |
Q4 2020 | $139,000 | -24.0% | 69,741 | +8.6% | 0.00% | -100.0% |
Q3 2020 | $183,000 | -78.4% | 64,224 | -72.0% | 0.00% | -75.0% |
Q2 2020 | $847,000 | +138.6% | 229,661 | +60.4% | 0.00% | +33.3% |
Q1 2020 | $355,000 | +38.1% | 143,209 | +114.1% | 0.00% | +200.0% |
Q4 2019 | $257,000 | +471.1% | 66,878 | +297.9% | 0.00% | – |
Q1 2019 | $45,000 | -34.8% | 16,809 | -42.7% | 0.00% | – |
Q4 2018 | $69,000 | +4.5% | 29,349 | +96.6% | 0.00% | – |
Q3 2018 | $66,000 | – | 14,928 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,172,044 | $2,625,000 | 2.31% |
Stonepine Capital Management, LLC | 782,817 | $1,754,000 | 0.80% |
5AM Venture Management, LLC | 1,134,511 | $2,541,000 | 0.52% |
Omega Fund Management, LLC | 2,005,249 | $4,492,000 | 0.50% |
BVF INC/IL | 4,776,904 | $10,700,000 | 0.42% |
KNOTT DAVID M | 415,308 | $930,000 | 0.34% |
West Family Investments, Inc. | 368,910 | $826,000 | 0.21% |
Monashee Investment Management LLC | 369,099 | $827,000 | 0.15% |
JEPPSON WEALTH MANAGEMENT, LLC | 60,100 | $134,000 | 0.07% |
Pacifica Partners Inc. | 8,000 | $18,000 | 0.01% |